Covers exenatide, semaglutide, tirzepatide, oral Wegovy, retatrutide, CagriSema, and the evolution from diabetes to obesity treatment.
These changes can appear with any semaglutide product, including: Wegovy Rybelsus With other GLP-1 agonists Descriptions include altered discharge color or consistency, changes in odor, decreased lubrication, increased infections, and visible loss of fullness in the pubic mound or labia
Headlines this week about a study showing an association between the fatty acids in fish oil and the development of prostate cancer have stirred concerns about consuming fish and fish oil supplements
10.1080/15226514.2010.495147 156 ShuklaD.KesariR.MishraS.DwivediS.TripathiR
Using targeted support can make the adjustment to a new dosing schedule feel much more manageable
European Journal of Clinical Pharmacology